General information

Warning

Treatment choices

1st line treatment for all patients: methylphenidate

Xaggitin XL is the GGC formulary preferred formulation.

2nd line treatment for all patients: atomoxetine, guanfacine or lisdexamfetamine

Pregnancy and breastfeeding

No medications for treatment of ADHD are recommended for use in pregnancy or breastfeeding. For further information refer to individual SPCs or BUMPS website.

Monitoring requirements

Blood pressure & pulse: Baseline, before and after dose changes, once stable 6 monthly.

Weight: 6 monthly

Height: 6 monthly for children and adolescents with growth chart completion.

Mental health status: Assess for development or deterioration of pre-existing conditions at each dose change, at each visit and 6 monthly.

ECG: Baseline and after dose changes are only necessary in patients with a history of congenital prolonged QTc syndrome or previous drug induced prolonged QTc.

Useful resources

Choice and medication offers a wide range of patient information leaflets for mental health conditions and the medication used to treat them.

Crisis Counselling (counselling service that works with people to achieve better mental health)

Cruse Scotland (bereavement support)

The Spark - Igniting Change (charity that provides counselling and mental health support services) 

Editorial Information

Last reviewed: 24/01/2025

Next review date: 01/12/2026

Author(s): PMG-MH.

Version: 1

Approved By: PMG-MH

Reviewer name(s): Lead Clinical Pharmacist, Clinical Effectiveness Pharmacist.